We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Afinitor Gets Expanded Indication As Pediatric Brain Tumor Treatment
Afinitor Gets Expanded Indication As Pediatric Brain Tumor Treatment
September 7, 2012
The FDA has approved Novartis’ Afinitor to treat a rare brain tumor called subependymal giant cell astrocytoma (SEGA) in children, expanding its indication for the condition.